Pipelle for pregnancy in women undergoing single, autologous, embryo transfer

Not Applicable

Completed

• Conditions: Subfertility; Reproductive Health and Childbirth - Fertility including in vitro fertilisation

• Registration Number: ACTRN12614000626662
• Lead Sponsor: Auckland District Health Board

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-06-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 1300

Inclusion Criteria

Women planning to undergo autologous embryo transfer with any indication of subfertility

Exclusion Criteria

1. Have had any disruptive instrumentation within the uterine cavity (e.g. hysteroscopy, hysterosalpingogram, laparoscopy, surgically managed miscarriage or endometrial biopsy) within three months prior to day one of the planned embryo transfer cycle, or planning to undergo a procedure involving disruptive instrumentation at any stage during the study. Embryo transfer and intrauterine insemination procedures are not considered to cause disruptive instrumentation
2. Entered previously into this study or participation in another trial in the last 30 days
3. Any contraindication to endometrial biopsy, being pregnant and/or carrying a pregnancy to term
4. Not planning an embryo transfer (e.g. fertility preservation or planned freeze-all cycles)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ive birth - delivery of a live infant at least 20 weeks gestation[Approximately 9 months after embryo transfer]